Impact of Simulation-based CME on Clinicians' Knowledge and Competence Related to Hypoglycemia Management

CMHC Clinical team conducted an analysis to determine if real-time patient simulation technology, designed to mimic an actual visit, could improve clinicians' knowledge and competence regarding the management of hypoglycemia patients with type 2 diabetes. The results were presented in a poster by the CMHC team- Shpetim Karandrea, Ph.D., Neha Agarwal Ph.D., and Amanda Jamrogiewicz, CHCP at the America Diabetes Association 80th Scientific Sessions.

The analysis methods included a live satellite patient simulation case and a pre/post assessment survey. The patient simulation encouraged clinicians to make treatment decisions on a patient with type 2 diabetes in order to optimize glycemic control, overcoming barriers to treatment intensification, minimizing the risk of hypoglycemia while fostering shared decision-making. Participants then got immediate feedback about their treatment choices based on patients' clinical characteristics and available evidence.

The educational effect of the simulation was measured using the administered pre/post assessment questions. The results demonstrated no difference in terms of clinical knowledge on barriers to T2DM treatment intensification; however, a significant impact on the practical application of the knowledge to individualize type 2 diabetes therapy in the context of hypoglycemic risk—including a significant increase in competence compared to baseline was observed.

The assessments additionally recorded information on participants' intended practice changes and educational gaps. Results demonstrate that following the activity, 63% of participants intend to provide diabetes education to patients to overcome treatment barriers, 51% intend to assess current guidelines for the management of hypoglycemic risk, and 34% intend to utilize anti-glycemic agents that minimize hypoglycemia. The analysis identified the failure to adequately individualize T2D therapy and hypoglycemia risk (21%) and the inability to recognize the benefits of GLP-1RA/insulin combinations (17%) among clinicians as ongoing educational gaps.

Our clinical team stated: "These results highlight that simulation-based CME activities can lead to significant improvements in competence about navigating the risk of hypoglycemia in type 2 diabetes management, as well as commitment to change among learners. Because of the rapidly changing landscape of type 2 diabetes management, additional education in this area is necessary, as demonstrated in some of the persisting gaps evidenced by our activity."

Link to the abstract:

Source & Acknowledgments:

Shpetim Karandrea, PhD; Neha Agarwal, PhD; and Amanda Jamrogiewicz, CHCP. Jointly provided by the Cardiometabolic Health Congress, University of Cincinnati, and Global Education Group. Supported by an independent educational grant from Sanofi US.